UBS lowered the firm’s price target on Constellation Brands (STZ) to $175 from $205 and keeps a Buy rating on the shares ahead of the Q2 earnings report on October 6. The company already lowered guidance in early September, so the print itself is unlikely to prove to be a major catalyst, the analyst tells investors in a research note. UBS believes downside is already priced in and that top line trends could improve on easier comparisons looking out to CY26.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STZ:
- Buy Rating Maintained for Constellation Brands Amidst Short-Term Challenges and Long-Term Growth Potential
- Berkshire to acquire OxyChem, OpenAI reaches $500B valuation: Morning Buzz
- Constellation Brands Amends By-Laws and Declares Dividend
- Constellation Brands CLO Bourdeau to retire, LaBarge to succeed
- Why Are Cannabis Stocks Up Today?